• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 16 Page 1 of 1
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1263
Bacillus coagulans PTA-127366 spore preparation Pending
  1145
β-lactoglobulin produced by Aspergillus oryzae strain Ao_st0002 Dec 18, 2023 FDA has no questions (in PDF) (236 kB)
  1111
Endo-1,4-β-xylanase enzyme preparation produced by Bacillus subtilis expressing the gene encoding xylanase from B. subtilis Feb 15, 2024 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (136 kB)
  981
Sterol esterase enzyme preparation produced by Trichoderma reesei expressing a gene encoding sterol esterase from Melanocarpus albomyces May 10, 2022 FDA has no questions (in PDF) (255 kB)
  979
Pectin esterase enzyme preparation produced by Aspergillus oryzae expressing a pectin esterase gene from A. tubingensis Oct 18, 2021 FDA has no questions (in PDF) (140 kB)
  954
Fibrillated cellulose Jun 10, 2021 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (111 kB)
  891
Cellulase produced by Trichoderma reesei Oct 20, 2020 FDA has no questions (in PDF)
  650
2'-O-fucosyllactose Nov 23, 2016 FDA has no questions Sep 11, 2020
Sep 9, 2020
  588
Zeaxanthin from Capsicum annum (paprika) Feb 29, 2016 FDA has no questions; some uses may require a color additive listing
  585
1-methylcyclopropene complex Jan 29, 2016 FDA has no questions
  576
Oligofructose and inulin Dec 9, 2015 FDA has no questions
  530
Extract of Apocynum venetum leaves Nov 5, 2014 At the notifier's request, FDA ceased to evaluate this notice
  503
Tamarind seed polysaccharide Aug 12, 2014 FDA has no questions
  325
Olestra Aug 30, 2010 FDA has no questions
  243
D-Ribose
   (Resubmission of GRN 100)
Nov 10, 2008 FDA has no questions
  100
D-Ribose Sep 3, 2002 Notice does not provide a basis for a GRAS determination
  243

GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-